Stay updated on Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial
Sign up to get notified when there's something new on the Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial page.
Latest updates to the Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial page
- Check6 days agoChange DetectedThe Vall d'Hebron Institute of Oncology has been updated to version v2.11.0, while previous notices regarding delays in study record information have been removed.SummaryDifference1%
- Check13 days agoChange DetectedClinicalTrials.gov is addressing delays in displaying study record information, with the latest update being version 2.10.5, which replaces version 2.10.3.SummaryDifference0.7%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3, indicating a new release.SummaryDifference0.1%
- Check35 days agoNo Change Detected
- Check49 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference1%
- Check63 days agoChange DetectedDifference1%
- Check64 days agoChange DetectedDifference1%
Stay in the know with updates to Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial page.